《新股消息》创世纪集团(01849.HK)超购8倍每股0.65元下限定价
创世纪集团控股(01849.HK)公布,以每股0.65元定价,为招股范围(每股0.65至0.7元)下限。所得款项净额为9,800万元,63.3%用作加强技术基础建设;28.5%用作收购网站开发及寄存公司;5.7%用作於马来西亚新山市设立销售办事处;2.5%供作一般营运资金。
公开发售部分超额认购8.03倍,因重新分配,配售予公开发售的发售股份最终数目已增至4,000万股发售股份,相当於根据股份发售可供认购发售股份总数20%。每手股份5,000股,一手中签率25%。
至於国际配售股份认购不足,相当於配售项下初步可供认购配售股份总数约0.89倍。
股份预期明日挂牌,保荐人为浩德融资。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.